Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
GC Biopharma Signs MOU with Thai Red Cross Society to Strengthen Collaboration on Plasma-Derived Therapies 2025-08-18 12:40
Ascletis Announces the Combination of ASC47 and ASC31, its Dual GLP-1R/GIPR Peptide Agonist, Demonstrated Significantly Greater Weight Loss Compared to the Combination of ASC47 and Tirzepatide in an Animal Model of Obesity 2025-08-18 08:15
GenScript Biotech Demonstrates Profitable Scale and Strategic Leadership in H1 2025, Establishing Clear Industry Leadership Through Accelerated Growth and Innovation 2025-08-17 20:01
VARON's Lung Health Awareness Initiative Urges Proactive Steps for Allergy and Flu this Fall Season 2025-08-15 23:08
Novel Gene Therapy for ALS cleared for global trials in China and the U.S. 2025-08-15 19:00
CARsgen Therapeutics Announces 2025 Interim Results 2025-08-15 08:15
Alpha Global partners with LIO to redefine Mental Health Care in Australia 2025-08-14 11:00
BioDlink Accelerates Global Expansion with Bevacizumab Launch in Colombia and Pakistan 2025-08-13 20:00
Daewoong Therapeutics Microneedle Patch Achieves Best-in-Class Bioavailability, Proving the Strength of Its Drug-Delivery Platform 2025-08-13 15:36
Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, Demonstrated Greater Efficacy with Tirzepatide than Semaglutide in a Preclinical Model 2025-08-13 07:00
VivaVision Strengthens Scientific Advisory Board with a World-Renowned Expert in Ophthalmology 2025-08-13 00:00
Mabwell Announces First Patient Dosed in the US Clinical Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated with ADCs 2025-08-12 22:00
Aquedeon Medical Inc. Receives FDA Approval to Expand Clinical Trial of Duett Vascular Graft System 2025-08-12 20:00
Fosun Pharma's Small Molecule Innovative Drug XH-S004 Achieves Overseas Licensing for a Potential Total of $645 Million 2025-08-12 09:36
AMI Pharm Advances AYP-101 to Phase 3, Paving the Way for a New Era in Fat-Reduction Injectable drugs 2025-08-11 20:00
Akeso Announces First Patient Dosed in Phase III Trial of Ivonescimab as Consolidation Therapy for Limited-Stage SCLC After Definitive Radiotherapy 2025-08-11 10:52
Hugel launches botulinum toxin Letybo in Malaysia 2025-08-11 08:30
Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System 2025-08-09 09:30
WuXi XDC Included in MSCI China All Share Index 2025-08-08 17:32
Minghui Pharmaceutical Announces USD 131 Million Pre-IPO Financing to Advance Late-Stage Pipeline and Global Expansion 2025-08-07 18:00
1 18 19 20 21 22 491